A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The curious minds at ColdFusion explore how a CRISPR breakthrough is allowing scientists to reverse certain types of blindness.

Scientists have gene-hacked mice to produce their own Ozempic-like drugs, paving a path for humans to do so themselves one ...

CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 10.96%. Read on to learn why. Crispr Therapeutics AG has seen a significant ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...

Japanese researchers have successfully gene-edited mice to produce exenatide, a diabetes drug similar to Ozempic, potentially revolutionizing treatment methods for the disease.

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary ...